Company intelligence / Profile preview

German Bionic

Augsburg, Bavaria, Germanygermanbionic.com ↗

Ownership: Private
Development stage: Commercial

Overview

German Bionic’s exoskeletons are commercially deployed in logistics, manufacturing, and healthcare settings. Clinical results focus on measurable reduction of workplace injuries and improved ergonomics. Devices like Apogee+ are optimized for hospital use; Exia offers up to 38 kg dynamic lift support with real-time AI-driven adaptation. The technology has received multiple innovation awards.

Therapeutic areas: OtherRheumatology
Modalities: Device (Wearable exoskeletons)
Industry: Assistive Medical Devices

Partnerships

Dachser Intelligent LogisticsGXO LogisticsNuremberg AirportCanadian Tire CorporationCurrys plc (UK)Charité Hospital Berlin

Beyond the preview

Go deeper on German Bionic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on German Bionic.

Explore the full profile